PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-101.75%
Both yoy net incomes decline, with SUM at -202.92%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-48.94%
Negative yoy D&A while SUM is 3.03%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
30.17%
SBC growth well above SUM's 43.14%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-455.12%
Both reduce yoy usage, with SUM at -133.21%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth while SUM is negative at -81.01%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
66.87%
Some inventory rise while SUM is negative at -120.98%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce yoy usage, with SUM at -412.06%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-76.09%
Negative yoy while SUM is 68.46%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-121.11%
Both yoy CFO lines are negative, with SUM at -99.78%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
64.19%
CapEx growth well above SUM's 18.19%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
93.40%
Some acquisitions while SUM is negative at -157.86%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
93.55%
Purchases growth of 93.55% while SUM is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-107.30%
Both yoy lines negative, with SUM at -88.05%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
83.83%
We have mild expansions while SUM is negative at -27.08%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
118.93%
Debt repayment above 1.5x SUM's 49.65%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-80.00%
Negative yoy issuance while SUM is 7.14%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
54.78%
Buyback growth at 50-75% of SUM's 100.00%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.